for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cutera, Inc.

CUTR.OQ

Latest Trade

37.50USD

Change

-0.08(-0.21%)

Volume

50,000

Today's Range

36.44

 - 

37.89

52 Week Range

12.33

 - 

38.76

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Cutera Appoints Fuad Ahmad As Interim CFO

Nov 18 (Reuters) - Cutera Inc <CUTR.O>::CUTERA APPOINTS FUAD AHMAD AS INTERIM CFO.CUTERA APPOINTS FUAD AHMAD AS INTERIM CFO.CUTERA INC - ANNOUNCED APPOINTMENT OF FUAD AHMAD TO ROLE OF INTERIM CHIEF FINANCIAL OFFICER, EFFECTIVE NOVEMBER 14, 2019.CUTERA - AHMAD WILL ASSUME OVERSIGHT OF CO'S FINANCE FUNCTION AND FINANCIAL REPORTING WHILE CO CONDUCTS ITS NATIONAL SEARCH FOR A PERMANENT CFO.

Cutera Posts Q3 Loss Per Share Of $0.19

Nov 7 (Reuters) - Cutera Inc <CUTR.O>::CUTERA REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.19.SEES FY 2019 REVENUE $177 MILLION TO $179 MILLION.Q3 REVENUE $46.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $41.7 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.06 -- REFINITIV IBES DATA.FULL-YEAR 2019 REVENUE IS EXPECTED TO BE $177 MILLION TO $179 MILLION.FULL-YEAR 2019 ADJUSTED EBITDA IS EXPECTED TO BE $3.5 MILLION TO $4.5 MILLION.SANDRA GARDINER, CUTERA'S CFO, ANNOUNCED HER RESIGNATION FROM CUTERA TO PURSUE ANOTHER OPPORTUNITY.GARDINER WILL CONTINUE AS CFO THROUGH NOVEMBER 15, 2019, AND WILL ASSIST IN TRANSITION.RETAINED SPENCER STUART TO CONDUCT A NATIONAL SEARCH TO IDENTIFY A REPLACEMENT FOR GARDINER.

Pulse Biosciences Announces Appointment Of Sandra Gardiner As CFO

Nov 7 (Reuters) - Pulse Biosciences Inc <PLSE.O>::PULSE BIOSCIENCES ANNOUNCES TRANSITION OF CHIEF FINANCIAL OFFICER.PULSE BIOSCIENCES INC - COMPANY ANNOUNCES APPOINTMENT OF SANDRA GARDINER AS CHIEF FINANCIAL OFFICER.PULSE BIOSCIENCES INC - BRIAN DOW HAS ELECTED TO RESIGN AS SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER.PULSE BIOSCIENCES INC - GARDINER WAS MOST RECENTLY EXECUTIVE VICE-PRESIDENT AND CHIEF FINANCIAL OFFICER OF CUTERA INC.

Cutera Reports Q2 Earnings Per Share $0.04

Aug 8 (Reuters) - Cutera Inc <CUTR.O>::CUTERA REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 EARNINGS PER SHARE $0.04.Q2 EARNINGS PER SHARE ESTIMATE $-0.03 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE UP 2 TO 8 PERCENT.SEES FY 2019 REVENUE $165 MILLION TO $175 MILLION.REVENUE GROWTH OF 12% OVER PRIOR YEAR.REVENUE INCREASED 12% OVER PRIOR YEAR Q2, TO $47.8 MILLION, HIGHEST QUARTERLY REVENUE IN COMPANY'S HISTORY.FULL YEAR 2019 GROSS MARGIN IS EXPECTED TO IMPROVE AS COMPARED TO FULL YEAR 2018 GROSS MARGIN.COMPANY'S FY ADJUSTED EBITDA IS EXPECTED TO BE IN RANGE OF $2 MILLION TO $4 MILLION.

Cutera Announces U.S. Commercial Launch Of Trusculpt Flex

June 26 (Reuters) - Cutera Inc <CUTR.O>::CUTERA REDEFINES THE MUSCLE SCULPTING MARKET WITH US COMMERCIAL LAUNCH OF TRUSCULPT® FLEX.CUTERA INC - ANNOUNCED U.S. LIMITED COMMERCIAL LAUNCH OF TRUSCULPT® FLEX, COMPANY'S NEW MUSCLE SCULPTING PLATFORM.

Cutera Posts Q1 GAAP Loss Per Share Of $0.59

May 9 (Reuters) - Cutera Inc <CUTR.O>::CUTERA REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 NON-GAAP LOSS PER SHARE $0.35.Q1 GAAP LOSS PER SHARE $0.59.SEES FY 2019 REVENUE UP 2 TO 8 PERCENT.SEES FY 2019 REVENUE $165 MILLION TO $175 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.21 -- REFINITIV IBES DATA.SEES 2019 ADJUSTED EBITDA TO BE IN THE RANGE OF $2 MILLION TO $4 MILLION.FY2019 REVENUE VIEW $167.4 MILLION -- REFINITIV IBES DATA.

Cutera Reports Fourth Quarter And Full Year 2018 Financial Results

Feb 20 (Reuters) - Cutera Inc <CUTR.O>::CUTERA REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.SEES FY 2019 REVENUE $165 MILLION TO $175 MILLION.Q4 GAAP LOSS PER SHARE $1.89.Q4 EARNINGS PER SHARE ESTIMATE $0.15 -- REFINITIV IBES DATA.REVENUE FOR Q4 INCREASED 12 PCT SEQUENTIALLY, THOUGH DECREASED 5 PCT FROM PRIOR YEAR Q4, TO $45.5 MILLION.ADJUSTED EBITDA IS EXPECTED TO BE IN RANGE OF $2 MILLION TO $4 MILLION FOR FY.

Cutera Sees FY 2018 Revenue About $161 Mln To $163 Mln

Jan 7 (Reuters) - Cutera Inc <CUTR.O>::CUTERA ANNOUNCES LEADERSHIP CHANGE AND PRELIMINARY FINANCIAL RESULTS FOR FULL YEAR 2018.SEES FY 2018 REVENUE UP 6 TO 8 PERCENT.SEES FY 2018 REVENUE ABOUT $161 MILLION TO $163 MILLION.CUTERA ANNOUNCES LEADERSHIP CHANGE AND PRELIMINARY FINANCIAL RESULTS FOR FULL YEAR 2018.COO JASON RICHEY TO SERVE AS INTERIM CEO.CEO JAMES REINSTEIN RESIGNS AS PRESIDENT, CHIEF EXECUTIVE OFFICER AND BOARD MEMBER.BOARD HAS FORMED A CEO SEARCH COMMITTEE THAT WILL BE CHAIRED BY DIRECTOR GREGORY BARRETT.

Cutera Q3 Non-Gaap Earnings Per Share $0.11

Nov 6 (Reuters) - Cutera Inc <CUTR.O>::CUTERA REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 NON-GAAP EARNINGS PER SHARE $0.11.Q3 GAAP LOSS PER SHARE $0.06.Q3 EARNINGS PER SHARE VIEW $0.03 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $0.40 TO $0.50.SEES FY 2018 REVENUE UP 9 TO 12 PERCENT.SEES FY 2018 REVENUE $165 MILLION TO $170 MILLION.Q3 REVENUE $40.6 MILLION VERSUS I/B/E/S VIEW $42.2 MILLION.

Cutera Inc Says Revising Full Year 2018 Revenue Guidance To $165 Mln To $170 Mln

Oct 4 (Reuters) - Cutera Inc <CUTR.O>::CUTERA INC - PRE-ANNOUNCED THAT COMPANY EXPECTS ITS REVENUES IN Q3 OF 2018 TO BE APPROXIMATELY $40 MILLION.CUTERA INC - REVISING FULL YEAR 2018 REVENUE GUIDANCE TO $165 MILLION TO $170 MILLION.CUTERA INC - FEW KEY FACTORS THAT NEGATIVELY IMPACTED Q3 RESULTS ARE EXPECTED TO CONTINUE INTO Q4.CUTERA INC - AMONG FACTORS ARE HEADWINDS FACED BY JULIET, DISTRIBUTED WOMEN'S HEALTH SYSTEM.CUTERA INC - BELIEVE THERE WAS A CLEAR IMPACT ON OVERALL MARKET FOLLOWING RECENT FDA COMMUNICATION TO MULTIPLE MANUFACTURERS.CUTERA INC - HIRING GOALS FOR US-BASED CAPITAL EQUIPMENT SALES PERSONNEL REMAIN UNMET.CUTERA INC - CUTERA DID NOT RECEIVE A NOTIFICATION FROM FDA, BELIEVE Q3 JULIET SALES WERE NEGATIVELY AFFECTED.CUTERA INC - HIRING GOALS FOR US-BASED CAPITAL EQUIPMENT SALES PERSONNEL REMAIN UNMET.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up